![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Free Subscription
2 Abdom Radiol (NY) |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Impact of virtual monochromatic images of different low-energy levels in
dual-energy CT on radiomics models for predicting muscle invasion in bladder
cancer.
Abdom Radiol (NY). 2024 Jun 27. doi: 10.1007/s00261-024-04459.
PubMed
Abstract available
Prognostic predictive value of urothelial carcinoma of the bladder after TURBT
based on multiphase CT radiomics.
Abdom Radiol (NY). 2024;49:1975-1986.
PubMed
Abstract available
Combinatorial Biosynthesis Creates a Novel Aglycone Polyether with High Potency
and Low Side Effects Against Bladder Cancer.
Adv Sci (Weinh). 2024 Jun 27:e2404668. doi: 10.1002/advs.202404668.
PubMed
Abstract available
Integrative Single Cell Atlas Revealed Intratumoral Heterogeneity Generation from
an Adaptive Epigenetic Cell State in Human Bladder Urothelial Carcinoma.
Adv Sci (Weinh). 2024;11:e2308438.
PubMed
Abstract available
An unusual "linitis plastica" like breast cancer bladder metastasis.
Arch Ital Urol Androl. 2024;96:12483.
PubMed
Abstract available
Relapse and Survival in Bladder Cancer Patients Undergoing microRNA-129 and
microRNA-145 Assays.
Asian Pac J Cancer Prev. 2024;25:2113-2121.
PubMed
Abstract available
Assessing risk of lymph node invasion in complete responders to neoadjuvant
chemotherapy for muscle-invasive bladder cancer.
BJU Int. 2024 Jun 24. doi: 10.1111/bju.16440.
PubMed
Abstract available
Real-world performance of Uromonitor(R) in urothelial bladder cancer detection: a
multicentric trial.
BJU Int. 2024 Jun 24. doi: 10.1111/bju.16450.
PubMed
Abstract available
Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among
Bladder Cancer Survivors.
Bladder Cancer. 2024;10:61-69.
PubMed
Abstract available
Inference of gene regulatory networks based on directed graph convolutional
networks.
Brief Bioinform. 2024;25:bbae309.
PubMed
Abstract available
Frontline immune checkpoint inhibitors in patients >/= 90 years with advanced
urothelial cancer: a single center experience.
Can J Urol. 2024;31:11875-11879.
PubMed
Abstract available
Atypical B cells promote cancer progression and poor response to Bacillus
Calmette-Guerin in non-muscle invasive bladder cancer.
Cancer Immunol Res. 2024 Jun 25. doi: 10.1158/2326-6066.CIR-23-1114.
PubMed
Abstract available
Impact of rural location on receipt of standard of care treatment and survival
for locally advanced bladder cancer in Louisiana.
Cancer Med. 2024;13:e7301.
PubMed
Abstract available
Avelumab first-line maintenance in advanced urothelial carcinoma: Complete
screening for prognostic and predictive factors using machine learning in the
JAVELIN Bladder 100 phase 3 trial.
Cancer Med. 2024;13:e7411.
PubMed
Abstract available
Marked Response to Nivolumab by a Patient With SMARCA4-Deficient Undifferentiated
Urothelial Carcinoma Showing High PD-L1 Expression: A Case Report.
Cancer Rep (Hoboken). 2024;7:e2127.
PubMed
Abstract available
Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D
Human Breast and Bladder Cancer Cell Lines.
Cancers (Basel). 2024;16:2227.
PubMed
Abstract available
Development of Traceable Mouse Models of Advanced and Metastatic Bladder Cancer.
Cancers (Basel). 2024;16:2245.
PubMed
Abstract available
Investigating angiogenin/ribonuclease 5 as a diagnostic biomarker for bladder
cancer: In-depth analysis from a systematic review and meta-analysis.
Clin Biochem. 2024 Jun 19:110780. doi: 10.1016/j.clinbiochem.2024.110780.
PubMed
Abstract available
Can Bladder MRI Improve the Follow-Up of Non-Muscle-Invasive Bladder Cancer by
Detecting Endoscopic Invisible Recurrence?
Clin Genitourin Cancer. 2024;22:102136.
PubMed
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with
TP53 Mutation: A Molecular-Directed Strategy.
Curr Oncol. 2024;31:3342-3349.
PubMed
Abstract available
A novel mitochondrial-related lncRNA signature mediated prediction of overall
survival, immune landscape, and the chemotherapeutic outcomes for bladder cancer
patients.
Discov Oncol. 2024;15:239.
PubMed
Abstract available
A case of urothelial carcinoma with successful continuation of enfortumab vedotin
without dose reduction despite grade 3 diffuse erythema with fever.
Eur J Dermatol. 2024;34:214-216.
PubMed
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer
Scoring System and Substratification Model Proposed by the International Bladder
Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group
Collaborati
Eur Urol Oncol. 2024 Jun 20:S2588-9311(24)00151.
PubMed
Abstract available
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A
Framework Based on Expert Practices Collaboratively Developed by the European
Association of Urology Bladder Cancer Guideline Panels.
Eur Urol Oncol. 2024 Jun 20:S2588-9311(24)00141.
PubMed
Abstract available
Case report: A novel somatic SDHB variant in a patient with bladder
paraganglioma.
Front Endocrinol (Lausanne). 2024;15:1386285.
PubMed
Abstract available
Assessing the predictive value of smoking history for immunotherapy outcomes in
bladder cancer patients.
Front Immunol. 2024;15:1404812.
PubMed
Abstract available
Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic
Urothelial Carcinoma.
In Vivo. 2024;38:1927-1934.
PubMed
Abstract available
Transcriptome Analysis in Patients With Muscle-invasive Bladder Cancer.
In Vivo. 2024;38:1660-1664.
PubMed
Abstract available
Expression of transferrin receptor/TFRC protein in bladder cancer cell T24 and
its role in inducing iron death in bladder cancer.
Int J Biol Macromol. 2024;274.
PubMed
Abstract available
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder
Cancer Patients.
Int J Mol Sci. 2024;25:6325.
PubMed
Abstract available
Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced
Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological
Implications.
Int J Mol Sci. 2024;25:6750.
PubMed
Abstract available
Prognostic significance of circulating tumor DNA in urothelial carcinoma: a
systematic review and meta-analysis.
Int J Surg. 2024;110:3923-3936.
PubMed
Abstract available
People-Oriented Nursing Mode on the Negative Emotions and Psychological Status of
Patients with Bladder Cancer.
Iran J Public Health. 2024;53:1087-1095.
PubMed
Abstract available
Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate
cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database
analysis.
J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505.
PubMed
Non-invasive screening of bladder cancer using digital microfluidics and FLIM
technology combined with deep learning.
J Biophotonics. 2024 Jun 28:e202400192. doi: 10.1002/jbio.202400192.
PubMed
Abstract available
A-to-I edited miR-154-p13-5p inhibited cell proliferation and migration and
induced apoptosis by targeting LIX1L in the bladder cancer.
J Cancer. 2024;15:3708-3723.
PubMed
Abstract available
Establishment of a SUMO pathway related gene signature for predicting prognosis,
chemotherapy response and investigating the role of EGR2 in bladder cancer.
J Cancer. 2024;15:3841-3856.
PubMed
Abstract available
Prevalence and oncologic impact of chronic kidney disease for upper tract
urothelial carcinoma in endemic area.
J Formos Med Assoc. 2024;123:758-763.
PubMed
Abstract available
MicroRNA-150-5p-mediated Inhibition of Cell Proliferation, G1/S Transition, and
Migration in Bladder Cancer through Targeting NEDD4-binding Protein 2-like 1
Gene.
J Physiol Investig. 2024;67:118-128.
PubMed
Abstract available
Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With
Bacillus Calmette-Guerin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year
Follow-Up From a Phase 3 Trial.
J Urol. 2024 Jun 24:101097JU0000000000004122. doi: 10.1097/JU.0000000000004122.
PubMed
Insight into Fructose-to-Sucrose Ratio as the Potential Target of Urinalysis in
Bladder Cancer.
Metabolites. 2024;14:345.
PubMed
Abstract available
The impact of venous thromboembolism before open or minimally-invasive radical
cystectomy in the USA: insurance claims data on perioperative outcomes and
healthcare costs.
Minerva Urol Nephrol. 2024;76:320-330.
PubMed
Abstract available
Loss of MTAP Expression by Immunohistochemistry Is a Surrogate Marker for
Homozygous 9p21.3 Deletion in Urothelial Carcinoma.
Mod Pathol. 2024;37:100495.
PubMed
Abstract available
Halogenated Boroxine K(2)[B(3)O(3)F(4)OH] Modulates Metabolic Phenotype and
Autophagy in Human Bladder Carcinoma 5637 Cell Line.
Molecules. 2024;29:2919.
PubMed
Abstract available
Lighting the torch: intratumoural T cell-to-stroma enrichment score as a
predictor of immunotherapy response in urothelial carcinoma.
Nat Rev Clin Oncol. 2024;21:487-488.
PubMed
Diet Quality and Risk of Bladder Cancer in the Multiethnic Cohort Study.
Nutrients. 2024;16:1965.
PubMed
Abstract available
Analysis of the short-term efficacy and impact on the quality of life of patients
with bladder cancer after surgery treated with Shenhu soup empirical formula
combined with bladder perfusion.
Panminerva Med. 2024 Jun 27. doi: 10.23736/S0031-0808.24.05136.
PubMed
Effect of FGFR alteration on prognosis in 1963 urothelial carcinoma patients with
immune checkpoint inhibitors: Implying combination of FGFR inhibitor and
immunotherapy for FGFR-altered urothelial carcinoma.
Pharmacol Res. 2024;205:107230.
PubMed
Abstract available
Comprehensive Collection of Whole-Slide Images and Genomic Profiles for Patients
with Bladder Cancer.
Sci Data. 2024;11:699.
PubMed
Abstract available
A novel signature constructed by mitochondrial function and cell death-related
gene for the prediction of prognosis in bladder cancer.
Sci Rep. 2024;14:14667.
PubMed
Abstract available
Identification of bladder cancer subtypes and predictive signature for prognosis,
immune features, and immunotherapy based on immune checkpoint genes.
Sci Rep. 2024;14:14431.
PubMed
Abstract available
Chemotherapy, immunotherapy, or combination first-line treatment for metastatic
urothelial carcinoma of the bladder: A large real-world experience.
Urol Oncol. 2024;42:291.
PubMed
Abstract available
Editorial Comment on "Social Vulnerability and Receipt of Neoadjuvant
Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer".
Urology. 2024 Jun 20:S0090-4295(24)00469-2. doi: 10.1016/j.urology.2024.
PubMed
Clinical upstaging after neoadjuvant chemotherapy impacting eligibility for
vaginal-sparing cystectomy: identifying bladder cancer patients who may benefit
from interim imaging.
Urology. 2024 Jun 20:S0090-4295(24)00474-6. doi: 10.1016/j.urology.2024.
PubMed
Abstract available
Sequential Intravesical Chemotherapy for Treatment Naive, High-Risk Non-Muscle
Invasive Bladder Cancer: Oncologic Outcomes, Tolerance, and Comparison to
Contemporary Controls.
Urology. 2024 Jun 19:S0090-4295(24)00463-1. doi: 10.1016/j.urology.2024.
PubMed
Abstract available
Transurethral Resection of Bladder Tumor Outcomes Are Predicted by a 5-Item
Frailty Index.
Urology. 2024;188:104-110.
PubMed
Abstract available
Thank you for your interest in scientific medicine.